InfuSystem Holdings, Inc (INFU) earnings date, results and what the price requires
NYSE · SEC CIK 0001337013 · SEC filings checked Oct 17, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 4, 2026 | $36.9M | $3.2M | $0.15 | Filing |
| Mar 31, 2026 | May 7, 2026 | $33.7M | $1.0M | $0.05 | Filing |
| Dec 31, 2025 | Feb 24, 2026 | $36.2M | $2.0M | $0.09 | Filing |
| Sep 30, 2025 | Nov 4, 2025 | $36.5M | $2.3M | $0.11 | Filing |
| Jun 30, 2025 | Aug 5, 2025 | $36.0M | $2.6M | $0.12 | Filing |
| Mar 31, 2025 | May 8, 2025 | $34.7M | $-267,000 | $-0.01 | Filing |
| Dec 31, 2024 | Mar 4, 2025 | $33.8M | $933,000 | $0.05 | Filing |
| Sep 30, 2024 | Nov 7, 2024 | $35.3M | $1.8M | $0.08 | Filing |
What would InfuSystem Holdings, Inc have to report for its valuation to change?
At $13.40, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 23.4% a year, to $1.15. On that path the next quarter needs diluted EPS near $0.14, against $0.11 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 23.4% | 23.4% |
| EPS needed in final year | $1.15 | $1.15 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. INFU goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.